Shelton Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-722
| Closed | -$237K | – | 707 |
|
|
2024
Q4 | $237K | Buy |
+722
| New | +$245K | 0.01% | 611 |
|
|
2020
Q3 | – | Sell |
-1,259
| Closed | -$568K | – | 764 |
|
|
2020
Q2 | $568K | Sell |
1,259
-58
| -4% | -$25.6K | 0.03% | 308 |
|
|
2020
Q1 | $462K | Sell |
1,317
-49
| -4% | -$18K | 0.04% | 305 |
|
|
2019
Q4 | $505K | Hold |
1,366
| – | – | 0.03% | 349 |
|
|
2019
Q3 | $455K | Hold |
1,366
| – | – | 0.03% | 371 |
|
|
2019
Q2 | $427K | Buy |
1,366
+929
| +213% | +$278K | 0.03% | 399 |
|
|
2019
Q1 | $1.43K | Sell |
437
-992
| -69% | -$268K | 0.01% | 813 |
|
|
2018
Q4 | $332K | Hold |
1,429
| – | – | 0.02% | 434 |
|
|
2018
Q3 | $447K | Hold |
1,429
| – | – | 0.03% | 399 |
|
|
2018
Q2 | $412K | Hold |
1,429
| – | – | 0.03% | 418 |
|
|
2018
Q1 | $357K | Sell |
1,429
-120
| -8% | -$30.6K | 0.02% | 475 |
|
|
2017
Q4 | $370K | Hold |
1,549
| – | – | 0.02% | 487 |
|
|
2017
Q3 | $344K | Hold |
1,549
| – | – | 0.02% | 498 |
|
|
2017
Q2 | $351K | Hold |
1,549
| – | – | 0.02% | 492 |
|
|
2017
Q1 | $309K | Hold |
1,549
| – | – | 0.02% | 560 |
|
|
2016
Q4 | $282K | Sell |
1,549
-564
| -27% | -$96.2K | 0.02% | 646 |
|
|
2016
Q3 | $346K | Hold |
2,113
| – | – | 0.03% | 514 |
|
|
2016
Q2 | $302K | Hold |
2,113
| – | – | 0.03% | 553 |
|
|
2016
Q1 | $289K | Hold |
2,113
| – | – | 0.03% | 577 |
|
|
2015
Q4 | $293K | Hold |
2,113
| – | – | 0.03% | 548 |
|
|
2015
Q3 | $284K | Hold |
2,113
| – | – | 0.03% | 563 |
|
|
2015
Q2 | $318K | Hold |
2,113
| – | – | 0.03% | 557 |
|
|
2015
Q1 | $286K | Hold |
2,113
| – | – | 0.03% | 616 |
|
|
2014
Q4 | $255K | Sell |
2,113
-174
| -8% | -$20K | 0.03% | 647 |
|
|
2014
Q3 | $259K | Hold |
2,287
| – | – | 0.03% | 605 |
|
|
2014
Q2 | $274K | Hold |
2,287
| – | – | 0.04% | 608 |
|
|
2014
Q1 | $293K | Hold |
2,287
| – | – | 0.04% | 543 |
|
|
2013
Q4 | $283K | Hold |
2,287
| – | – | 0.04% | 538 |
|
|
2013
Q3 | $269K | Hold |
2,287
| – | – | 0.05% | 517 |
|
|
2013
Q2 | $257K | Buy |
+2,287
| New | +$268K | 0.05% | 492 |
|
Other funds holding BIO
VAM
AI